← Back to Search

Monoclonal Antibodies

Omalizumab for Preventing Asthma in Kids (PARK Trial)

Phase 2
Waitlist Available
Led By Wanda Phipatanakul, MD, MS
Research Sponsored by Boston Children's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
24-47 months of age at randomization
2-4 wheezing episodes in the past year
Timeline
Screening 3 weeks
Treatment Varies
Follow Up final 12 months during 2 year observation period off study drug
Awards & highlights

PARK Trial Summary

This trial is testing whether a drug can prevent asthma in kids aged 2-3. It's double-blind, meaning neither the participants nor the researchers know who's receiving the drug or the placebo.

Who is the study for?
This trial is for preschool children aged 2-3 at high risk for asthma, who've had 2-4 wheezing episodes in the past year and a family history of asthma or allergy. They must not have used strong asthma medications recently, had frequent corticosteroid treatments, or have other significant medical conditions.Check my eligibility
What is being tested?
The study tests if treating these kids with Omalizumab (anti-IgE) can prevent them from developing childhood asthma compared to a placebo. It's randomized and double-blind, meaning neither the researchers nor participants know who gets the real treatment.See study design
What are the potential side effects?
Omalizumab may cause injection site reactions, viral infections like colds or ear infection, headaches, and possibly severe allergic reactions. The exact side effects will be monitored throughout the trial.

PARK Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 2 and 4 years old.
Select...
I have had 2-4 wheezing episodes in the last year.
Select...
I have been on a stable food allergy treatment not part of a trial for at least 2 months.

PARK Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~final 12 months during 2 year observation period off study drug
This trial's timeline: 3 weeks for screening, Varies for treatment, and final 12 months during 2 year observation period off study drug for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
active asthma diagnosis
asthma severity
Secondary outcome measures
decrease in number of wheezing episodes
number of positive new allergic sensitization

PARK Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: ActiveActive Control1 Intervention
omalizumab 0.016 mg/kg/IU total IgE
Group II: PlaceboPlacebo Group1 Intervention
looks like active drug

Find a Location

Who is running the clinical trial?

Boston Children's HospitalLead Sponsor
760 Previous Clinical Trials
5,579,480 Total Patients Enrolled
17 Trials studying Asthma
7,581 Patients Enrolled for Asthma
National Institute of Allergy and Infectious Diseases (NIAID)NIH
3,268 Previous Clinical Trials
5,480,932 Total Patients Enrolled
58 Trials studying Asthma
11,335 Patients Enrolled for Asthma
Wanda Phipatanakul, MD, MSPrincipal Investigator - Boston Children's Hospital
Boston Children's Hospital
Loma Linda University School Of Medicine (Medical School)
Johns Hopkins University School Medicine (Residency)
4 Previous Clinical Trials
1,139 Total Patients Enrolled
4 Trials studying Asthma
1,139 Patients Enrolled for Asthma

Media Library

Omalizumab (Monoclonal Antibodies) Clinical Trial Eligibility Overview. Trial Name: NCT02570984 — Phase 2
Asthma Clinical Trial 2023: Omalizumab Highlights & Side Effects. Trial Name: NCT02570984 — Phase 2
Omalizumab (Monoclonal Antibodies) 2023 Treatment Timeline for Medical Study. Trial Name: NCT02570984 — Phase 2

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there other investigations concerning Active already in progress?

"Currently, 22 investigations analyzing Active are live with 6 of those experiments in Phase 3. Most trials for Active are being conducted at the Jerez de la Frontera location, but there is a total of 254 locations running tests on Active."

Answered by AI

How many medical centers are engaged in this research trial?

"This research is recruiting individuals at Childrens Hospital Colorado in Aurora, Ohio, Cincinnati Children's Medical Centre in Cincinnati and Connecticut Children's Hospital in Hartford as well as thirteen additional medical centres."

Answered by AI

Is this research actively recruiting participants?

"Data on clinicaltrials.gov shows this trial is still actively recruiting participants, having first been listed on 27th November 2018 and edited most recently on 13th January 2022."

Answered by AI

To what extent does Active pose a risk to patients' well-being?

"With the current evidence, Active is assessed as a 2 on our team's 1-3 scale. This rating reflects that we have some data validating its safety but none confirming efficacy at this Stage 2 trial."

Answered by AI

What medical complaints is Active typically administered to combat?

"Active can be utilized to mitigate symptoms caused by perennial aeroallergen reactivity and effectively manage the effects of inhaled corticosteroids, histamine h1 antagonists, non-sedating medications, and moderate asthma."

Answered by AI

Is it possible to join this clinical research experiment?

"The trial is searching for a total of 200 individuals who have asthma and fall within the age range of 24 Months - 47 Months."

Answered by AI

Is this investigation open to individuals over the age of 35?

"This clinical trial is open to children between two years old and almost four years old. An additional 119 studies are available for minors, while 211 trials are hosted specifically for senior citizens."

Answered by AI

What is the scale of participation in this clinical research?

"To successfully conduct this clinical trial, 200 participants must meet the set criteria and join from locations such as Childrens Hospital Colorado in Aurora or Cincinnati Children's Hospital Medical Center."

Answered by AI
~82 spots leftby Jan 2028